Device Trial Radar · NCT03246984
VALUE- Vascular Access Laminate eUropean Experience. A Post Market Surveillance Study to Assess the Safety and Effectiveness of VasQ
Last checked: Nov 19, 2026Latest source record: Jan 31, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
80
Actual
Start
Sep 7, 2017
Primary completion
Jan 11, 2021
Study completion Jan 11, 2021
Sponsor
- Lead sponsor
- Laminate Medical TechnologiesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 11, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective single arm study enrolling patients who are scheduled for creation of a new Brachiocephalic or Radiocephalic AV fistula. Up to 80 patients will be enrolled, 50 with upper arm AV fistula and 30 with forearm AV fistula. All patients will be implanted with the VasQ device, a subcutaneous arteriovenous conduit support for vascular access. The follow up period in this study will be for a duration of 12 months, with follow up visits scheduled at 1, 3, 6, 9, and 12 months.
Conditions
- Arterio-Venous Fistula
- Kidney Failure, Chronic
- Kidney Diseases
- Renal Failure Chronic
- ESRD
- Arteriovenous Fistula Thrombosis
Interventions
VasQDevice
VasQ device implantation in patients with a new brachiocephalic or radiocephalic fistula creation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary patency of AV fistulaTime frame: 6 months post AVF creation
Locations
11 sites in 4 countries. Site status is shown where the registry gives one.
Institut Mutualiste Montsouris
Paris, France
Universitätsklinikum Augsburg
Augsburg, Germany
Charité - Universitätsmedizin Berlin
Berlin, Germany
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.